Soliqua 100/33 (insulin glargine/lixisenatide) is a prescription drug that’s used to treat type ... Soliqua 100/33 isn’t available in a biosimilar form. (Biosimilars are like generic drugs.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Both products contain the same active ingredients and dosage formulations but are marketed ... A month's supply of a daily maintenance dose containing lixisenatide and 30 units of insulin glargine (a ...

When a GLP-1 drug similar to Ozempic helped slow Parkinson's symptoms A recent New England Journal of Medicine study tested lixisenatide, a GLP-1 drug, as a potential treatment for early-stage ...

Objective: To review drug interaction studies of glucagon-like ... liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English and conducted in adults.

The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...

The dosage for bupropion varies depending on the condition it’s being used to treat and the form of the drug you’re prescribed. Your doctor will prescribe the dosage and form that’s best for ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

The prescribed dosage for fluoxetine may depend on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

When a drug-sniffing dog named Eureka flagged one of his bags, inspectors reportedly found two plastic jars and a Ziploc bag with candy inside.

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...